On 2025-09-29, Neuphoria Therapeutics Inc. (NEUP) announced earnings per share of $-5.79 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-0.56.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-09-29 | 2025-06-30 | $-0.56 | $-5.79 |
| 2025-05-20 | 2025-03-31 | $-0.47 | $6.55 |
| 2025-02-14 | 2024-12-31 | $-2.01 | $-1.23 |